| Literature DB >> 16151389 |
Abstract
At the end of next month, the European Medicines Agency (EMEA) will implement a new legislative framework and several provisions that seek to provide incentives and streamline regulatory oversight of certain monoclonal antibodies and other biologic products.Mesh：
Substances：
Year: 2005 PMID： 16151389 DOI： 10.1038/nbt0905-1050
Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908